Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluating Glucose Control Using a Next-Generation AID Algorithm in Individuals With T1D

NCT: NCT07593625 · RECRUITING

NCT IDNCT07593625
StatusRECRUITING
Start Date2026-05-25
Completion2027-02-01
SponsorInsulet Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

Feasibility study to evaluate the safety and feasibility of Omnipod automated insulin delivery algorithms in individuals with type 1 diabetes. This study will enroll up to 80 participants to have a minimum of 48 participants to initiate the use of Omnipod. The study will include hotel and outpatient evaluation periods.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑